Pediatric Exclusivity Revenues for Cancer Drugs

JAMA Pediatr. 2025 Jan 1;179(1):91-93. doi: 10.1001/jamapediatrics.2024.4449.
No abstract available

Plain language summary

This cohort study calculates the cost of pediatric trials and the value of pediatric exclusivity for select cancer drugs.